Wexford, PA, United States of America

Larry Vernetti

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2021-2024.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents
where one patent can have more than one assignee

Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Larry Vernetti: Innovator in Liver Microphysiology

Introduction

Larry Vernetti is a notable inventor based in Wexford, PA (US). He has made significant contributions to the field of liver microphysiology, holding 2 patents that focus on innovative microfluidic devices. His work aims to advance the understanding and modeling of liver functions through advanced tissue structures.

Latest Patents

Vernetti's latest patents include the "Human liver microphysiology platform and self-assembly liver acinus model and methods of their use." This patent describes microfluidic devices designed for modeling three-dimensional tissue structures, along with methods for their creation and application. These inventions are crucial for developing better models for studying liver functions and diseases.

Career Highlights

Throughout his career, Larry Vernetti has been dedicated to enhancing the field of biomedical engineering. His innovative approaches have led to the development of tools that can significantly impact research and therapeutic strategies related to liver health.

Collaborations

Some of his notable coworkers include D Lansing Taylor and Albert H Gough. Their collaborative efforts have contributed to the advancement of research in liver microphysiology and related fields.

Conclusion

Larry Vernetti's work exemplifies the intersection of innovation and healthcare, particularly in liver research. His patents and collaborative efforts continue to pave the way for advancements in biomedical engineering.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…